Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982410 · ClinicalTrials.gov registry record · Early Phase 1
Managing Chronic Pain in Veterans With Substance Use Disorders
A Early Phase 1 study of Chronic Pain, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 131
- Enrollment target
- 1
- Study location
NCT00982410: Completed Early Phase 1 study of Chronic Pain, sponsored by US Department of Veterans Affairs.
NCT00982410 is a Early Phase 1 study of Chronic Pain that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 131 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00982410, a Early Phase 1 study of Chronic Pain, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 131 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project will provide crucial data on the effectiveness of a pain management intervention designed for veterans with co-occurring pain and substance use disorders. The development of an empirically validated psychosocial intervention for managing pain and substance misuse could greatly enhance the current set of options for treating this large and understudied group of veterans.
Primary Outcome
The outcome measure below represents the average pain levels in each Arm/Group, across the entire follow-up period. Average pain in the last week (NRS-1) is a scale ranging from 0 (no pain) to 10 (worst possible pain). The results reported below are based on longitudinal repeated measures modeling, adjusted for baseline NRS-1 average pain level. The variance was modeled to account for time interval (3-mo, 6-mo, 12-mo), and for session block; at the time of randomization, participants were assign
Conditions Studied
Interventions
- BEHAVIORAL cognitive-behavioral treatment
- BEHAVIORAL educational supportive group
Study Locations (1)
Michigan
- VA Ann Arbor Healthcare System - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-03 |
| Phase | Early Phase 1 |
What the finished NCT00982410 record still lists
NCT00982410 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which cognitive-behavioral treatment is the first listed.
NCT00982410 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00982410 about?
NCT00982410 is a clinical study titled "Managing Chronic Pain in Veterans With Substance Use Disorders". The proposed project will provide crucial data on the effectiveness of a pain management intervention designed for veterans with co-occurring pain and substance use disorders. The development of an empirically validated psychosocial intervention for managing pain and substance misuse could greatly e...
What is the current status of trial NCT00982410?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 131 participants. The study started on 2010-04. Estimated completion is 2014-03.
What conditions does trial NCT00982410 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT00982410?
The interventions under investigation include: cognitive-behavioral treatment (BEHAVIORAL), educational supportive group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00982410?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00982410 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00982410's enrollment target sits among peer trials
131 112th of 301 higher than 190 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabidiol in Opioid Use Disorder and Chronic Pain
RECRUITING · Early Phase 1
-
Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
RECRUITING · Early Phase 1
-
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction
ACTIVE NOT RECRUITING · Early Phase 1
-
Immunologic Response to Negative Cognition in Persons With Chronic Pain
COMPLETED · Early Phase 1
-
Non-Opioid Pramipexole and Pain
COMPLETED · Early Phase 1
-
Exploratory Evaluation of [11C]-NOP46
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia